Epstein-barr virus induces Fas (CD95) in T cells and fas ligand in B cells leading to T-cell apoptosis

Blood

Volumn 94, Issue 10, 1999, Pages 3439-3447

  Tanner, Jerome E ^a   Alfieri, Caroline ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GLYCOPROTEIN GP 350; INTERLEUKIN 2; MITOGENIC AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOMODULATION; IN VITRO STUDY; INFECTIOUS MONONUCLEOSIS; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VIRION;

EID: 0033570944     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.10.3439.422k23_3439_3447     Document Type: Article

References (59)

1. Henle W, Henle G: Epstein-Barr virus and infectious mononucleosis. N Engl J Med 288:263, 1973
2. Tosato G, Taga K, Angiolillo AL, Sadari C: Epstein-Barr virus as an agent of haematological disease. Clin Haematol 8:165, 1995
3. Khanna R, Burrows SR, Moss DJ: Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 59:387, 1995
4. De Waele M, Thielmans C, Van Camp BKG: Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N Engl J Med 304:460, 1981
5. Yoneyama A, Nakahara K, Higashihara M, Kurokawa K: Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis. Br J Haematol 89:47, 1995
6. Biglino A, Sinicco A, Forno B, Pollono AM, Sciandra M, Martini C, Pich P, Gioannini P: Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol 78:61, 1996
7. Perez-Blas M, Regueiro JR, Ruiz-Contreras JR, Arnaiz-Villena A: T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway. Clin Exp Immunol 89:83, 1992
8. Moss DJ, Bishop CJ, Burrows SR, Ryan JM: T lymphocytes in infectious mononucleosis. I. T cell death in vitro. Clin Exp Immunol 60:61, 1985
9. Uehara T, Miyawaki K, Ohata Y, Tamaru T, Yokoi S, Nakamura S, Taniguchi N: Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus induced infectious mononucleosis. Blood 80:452, 1992
10. Tamaru, Y, Miyawaki T, Iwai K, Tsuji T, Nibu R, Yachie A, Koizumi S, Taniguchi N: Presence of bcl-2 expression by activated CD45RO+ T lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 82:521, 1993
11. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Posting H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709, 1992
12. Cleveland JL, Ihle JN: Contenders in Fas/TNF death signaling. Cell 81:479, 1995
13. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas(CD95)/Fas-L interactions required for programmed cell death after T cell activation. Nature 373:444, 1995
14. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620, 1990
15. Razvi ES, Welsh RM: Apoptosis in viral infections. Adv Virus Res 45:1, 1995
16. Sieg S, Huang Y, Kaplan D: Viral regulation of CD95 expression and apoptosis in T lymphocytes. J Immunol 159:1192, 1997
17. Ito M, Watanabe M, Ihara T, Kamiya H, Sakuiai M: Fas antigen and bcl-2 expression on lymphocytes cultured with cytomegalovirus and varicella-zoster virus antigen. Cell Immunol 160:173, 1995
18. Inoue Y, Yasukawa M, Fujita S: Induction of T cell apoptosis by human herpesvirus 6. J Virol 71:3751, 1997
19. Esolen LM, Park SW, Hardwick JM, Griffin DE: Apoptosis as a cause of death in measles virus-infected cells. J Virol 69:3955, 1995
20. Yoshida H, Sumichika H, Hamano S, He X, Minamishima Y, Kimura G, Nomoto K: Induction of apoptosis of T cells by infected mice with murine cytomegalovirus. J Virol 69:4768, 1995
21. Hayashi EM, Iio S, Hijioka T, Kasahara A, Fusamoto H, Kamada T: Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 204:468, 1994
22. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S: Cross-linking CD4 molecules upregulates FAS antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 84:2622, 1994
23. Tanner J, Weis J, Fearon D, Whang Y, Kieff E: Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50:203, 1987
24. Tsoukas CD, Lambris JD: Expression of CR2/EBV receptors on human thymocytes detected by monoclonals. Eur J Immunol 18:1299, 1987
25. Birkenbach M, Tong X, Bradbury LE, Tedder T, Kieff E: Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 176:405, 1992
26. Hedrick JA, Lao Z, Lipps SG, Wang Y, Todd SC, Lambris JD, Tsoukas CD: Characterization of a 70-kDa, EBV gp350/220 binding protein on HSB-2 T cells. J Immunol 153:4418, 1994
27. Tanner JE, Alfieri C, Diaz-Mitoma F: Induction of interleukin-6 (IL-6) following stimulation of human B cell CD21 by the Epstein-Barr virus glycoproteins gp350 and gp220. J Virol 70:570, 1996
28. Bailey RE: Diagnosis and treatment of infectious mononucleosis. Am Fam Physician 49:879, 1994
29. Takada K: Crosslinking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33:27, 1984
30. Saxon A, Fieldhaus J, Robins RA: Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods 12:285, 1976
31. Foung SKH, Coutre S, Engleman G: Separation of human T and non-T lymphocytes from peripheral blood. In Engleman EG, Foung SKH, Larrick J, Raubitschek A (eds): Human Hybridomas and Monoclonal Antibodies. New York, NY, Plenum, 1985, p 437
32. Gordon J, Walker L, Guy G, Brown G, Rowe M, Rickinson A: Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B cell growth. Immunology 58:591, 1986
33. Dolyniuk M, Pritchett R, Kieff E: Proteins of Epstein-Barr virus. I Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J Virol 17:289, 1976
34. Hoffman GJ, Sondra GL, Hayward SD: Monoclonal against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc Natl Acad Sci USA 77:2979, 1980
35. Tanner J, Whang Y, Sample J, Sears A, Kieff E: Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes. J Virol 62:4452, 1988
36. Morrissey SH: Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity. Anal Biochem 117:307, 1981
37. Groux H, Topier G, Monte D, Mouton Y, Capron A, Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331, 1992
38. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi CA: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
39. Durandy A, LeDeist F, Emile JF, Debatin K, Fisher A: Sensitivity of Epstein-Barr virus-induced B cell tumor apoptosis mediated by anti-CD95/Apo-1/fas antibody. Eur J Immunol 27:538, 1997
40. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of fas (CD95) and fas ligand on normal human phagocytes: Implications for regulation of apoptosis in neutrophils. J Exp Med 184:429, 1996
41. Anagnostopoulos I, Hummel H, Kreschel C, Stein H: Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the inter individual infection route of Epstein-Barr virus. Blood 85:744, 1995
42. Prang NS, Hornef MW, Jager M, Wagner HJ, Wolf H, Schwarzmann FM: Lytic replication of Epstein-Ban virus in peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665, 1997
43. Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS: Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells. J Pathol 182:151, 1997
44. Karajannis MA, Hummel M, Anagnostopoulos I, Stein H: Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleossis in nonimmunocompromised individuals. Blood 89:2856, 1997
45. Thorley-Lawson DA, Myashita EM, Khan G: Epstein-Barr virus and the B cell: That's all it takes. Trends Microbiol 4:204, 1996
46. Levy E, Ambrus J, Kahl L, Molina H, Tung K Holers VM: T lymphocyte expression of complement receptor 2 (CR2/CD21): A role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosis (SLE). Clin Exp Immunol 90:235, 1992
47. Haynes BF, Schooley RT, Payling-Wright CR, Grouse JE, Dolin R, Fauci AS: Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol 123:2095, 1979
48. Moore KW, Viera P, Fiorentino DF, Trounstine ML, Khan TA, Mossmann TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF-1. Science 248:1230, 1990
49. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209, 1991
50. Alfieri, C, Birkenbach M, Kieff E: Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 18:595, 1994
51. Baker SJ, Reddy ED: Transducers of life and death: TNF receptor specificity and associated TRAF proteins. Oncogene 12:1, 1996
52. Wu M, Dayley JF, Rasmussen RA, Schlossman SF: Monocytes are required to promote peripheral blood T cells to undergo apoptosis. Proc Natl Acad Sci USA 92:1525, 1995
53. Oyaizu, N, Adachi Y, Hashimoto F, McCloskey TW, Hosaka N, Kayagaki N, Yagita H, Pahwa S: Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cell apoptosis. J Immunol 158:2456, 1997
54. Boudet F, Lecoeur H, Gougeon ML: Apoptosis associated with ex vivo down-regulation of bcl-2 and upregulation of fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 156:2282, 1996
55. Boussiotis V, Lee BJ, Freeman GJ, Gribben JG, Nadler LM: Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes susceptibility to fas-and bax-mediated programmed cell death. J Immunol 159:3156, 1997
56. Callan MFC, Steven N, Krausa P, Wilson JDK, Moss PAH, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ: Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 2:906, 1996
57. Steven NM, Annels NE, Kumar A, Leese AM, Kurilla MG, Rickinson AB: Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med 185:1605, 1997
58. Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM, Moss DJ, Agaet VP, Miski IS: Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med 184:1815, 1996
59. Lynch, DH, Ramsdell R, Anderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569, 1995